Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-K/A: Annual report (Amendment)
Spyre Therapeutics | 8-K: Spyre Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Spyre Therapeutics | 10-Q: Q3 2024 Earnings Report
Spyre Therapeutics | 8-K: Spyre Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Spyre Therapeutics | 10-Q: Q2 2024 Earnings Report
Spyre Therapeutics | 8-K: Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Spyre Therapeutics | 10-Q: Q1 2024 Earnings Report
Spyre Therapeutics | 10-K/A: Annual report (Amendment)
Spyre Therapeutics | 8-K: Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Spyre Therapeutics | 10-K: FY2023 Annual Report
Aeglea BioTherapeutics | 10-Q: Q3 2023 Earnings Report
Aeglea BioTherapeutics | 8-K: Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Aeglea BioTherapeutics | 10-Q: Q2 2023 Earnings Report
Aeglea BioTherapeutics | 8-K: Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
Aeglea BioTherapeutics | 10-Q: Q1 2023 Earnings Report
Aeglea BioTherapeutics | 8-K: Aeglea BioTherapeutics Reports First Quarter 2023 Financial Results
Aeglea BioTherapeutics | 10-K: FY2022 Annual Report
Unlock the Full List